The findings come from a highly anticipated clinical trial looking at whether the antimalarial drug touted by President Donald Trump might prevent the illness caused by the coronavirus.
At the end of the two weeks, there was virtually no difference in who developed COVID-19 symptoms. About 12 percent of those given hydroxychloroquine reported symptoms, compared with 14 percent who received the placebo. Adding zinc or vitamin C supplements did not show a benefit, either, the researchers reported.
Despite concerns the drug might lead to dangerous heart problems, the researchers did not find that was the case in this study. However, people who received hydroxychloroquine were more likely to have nausea or diarrhea. The new findings from the University of Minnesota Medical School largely relied on participants to report symptoms of COVID-19, as diagnostic tests were largely inaccessible. This means some participants indeed could have become infected, but never developed symptoms, such as fever, cough, shortness of breath and stomach issues.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
WHO committee recommends continued study of hydroxychloroquine as a potential Covid-19 treatmentThe coronavirus pandemic has brought countries to a standstill. Here's the latest updates on Covid-19 cases, deaths, government responses and more.
続きを読む »
WHO set to resume hydroxychloroquine trial in battle against COVID-19The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
続きを読む »
WHO set to resume hydroxychloroquine trial in battle against COVID-19The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
続きを読む »
WHO Restarts Hydroxychloroquine Trials For Covid-19 After Data Showing Increased Risk Called Into QuestionTwo articles in reputable medical journals showing an increased risk of death from hydroxychloroquine are undergoing scrutiny after reports suggesting suspect data.
続きを読む »
No Evidence Hydroxychloroquine Is Helpful In Preventing COVID-19, Study FindsA study of more than 800 health workers, first responders and others finds that taking hydroxychloroquine to prevent COVID-19 is no better than a placebo in preventing the illness.
続きを読む »